Historical Valuation
Arcosa Inc (ACA) is now in the Fair zone, suggesting that its current forward PE ratio of 23.51 is considered Fairly compared with the five-year average of 26.14. The fair price of Arcosa Inc (ACA) is between 107.25 to 144.54 according to relative valuation methord.
Relative Value
Fair Zone
107.25-144.54
Current Price：111.42
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Arcosa Inc (ACA) has a current Price-to-Book (P/B) ratio of 2.03. Compared to its 3-year average P/B ratio of 1.70 , the current P/B ratio is approximately 19.14% higher. Relative to its 5-year average P/B ratio of 1.57, the current P/B ratio is about 28.97% higher. Arcosa Inc (ACA) has a Forward Free Cash Flow (FCF) yield of approximately 6.01%. Compared to its 3-year average FCF yield of 2.80%, the current FCF yield is approximately 114.61% lower. Relative to its 5-year average FCF yield of 3.35% , the current FCF yield is about 79.36% lower.
P/B
Median3y
1.70
Median5y
1.57
FCF Yield
Median3y
2.80
Median5y
3.35
Competitors Valuation Multiple
AI Analysis for ACA
The average P/S ratio for ACA competitors is 2.94, providing a benchmark for relative valuation. Arcosa Inc Corp (ACA.N) exhibits a P/S ratio of 1.74, which is -40.99% above the industry average. Given its robust revenue growth of 24.58%, this premium appears sustainable.
Performance Decomposition
AI Analysis for ACA
1Y
3Y
5Y
Market capitalization of ACA increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ACA in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is ACA currently overvalued or undervalued?
Arcosa Inc (ACA) is now in the Fair zone, suggesting that its current forward PE ratio of 23.51 is considered Fairly compared with the five-year average of 26.14. The fair price of Arcosa Inc (ACA) is between 107.25 to 144.54 according to relative valuation methord.
What is Arcosa Inc (ACA) fair value?
ACA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Arcosa Inc (ACA) is between 107.25 to 144.54 according to relative valuation methord.
How does ACA's valuation metrics compare to the industry average?
The average P/S ratio for ACA's competitors is 2.94, providing a benchmark for relative valuation. Arcosa Inc Corp (ACA) exhibits a P/S ratio of 1.74, which is -40.99% above the industry average. Given its robust revenue growth of 24.58%, this premium appears sustainable.
What is the current P/B ratio for Arcosa Inc (ACA) as of Jan 10 2026?
As of Jan 10 2026, Arcosa Inc (ACA) has a P/B ratio of 2.03. This indicates that the market values ACA at 2.03 times its book value.
What is the current FCF Yield for Arcosa Inc (ACA) as of Jan 10 2026?
As of Jan 10 2026, Arcosa Inc (ACA) has a FCF Yield of 6.01%. This means that for every dollar of Arcosa Inc’s market capitalization, the company generates 6.01 cents in free cash flow.
What is the current Forward P/E ratio for Arcosa Inc (ACA) as of Jan 10 2026?
As of Jan 10 2026, Arcosa Inc (ACA) has a Forward P/E ratio of 23.51. This means the market is willing to pay $23.51 for every dollar of Arcosa Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Arcosa Inc (ACA) as of Jan 10 2026?
As of Jan 10 2026, Arcosa Inc (ACA) has a Forward P/S ratio of 1.74. This means the market is valuing ACA at $1.74 for every dollar of expected revenue over the next 12 months.